Virus News and Research

Latest Virus News and Research

Functional impairment of HIV-specific T cells precedes aborted virus control

HIV is a master of evading the immune system, using a variety of methods to prevent the body from being able to find and kill it.

13 Sep 2021

As COVID restrictions were removed, Texas saw an increase in seasonal respiratory virus infections

Like many US states, Texas introduced many different measures to reduce the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as masking, social distancing, and the closure of public services and businesses likely to aid the spread of disease.

13 Sep 2021

An investigation of SARS-CoV-2 infections among Australian passengers on the Diamond Princess cruise ship

The Diamond Princess Cruise ship left Yokohama (Japan) on 20 January 2020, for a fourteen-day tour with shore excursions in Japan, Hong Kong, Vietnam, and Taiwan. Unfortunately, one of the passengers who complained of mild dry cough was later confirmed to be SARS-CoV-2 positive. In due course, 19% of the passengers were infected with the virus, and thirteen people died.

13 Sep 2021

Acid pH enhances SARS-CoV-2 infection by up-regulating ACE2 receptor

A new study published in the journal Frontiers of Medicine indicated that Barrett's esophagus (BE) and gastroesophageal reflux disease (GERD) may represent novel comorbidities associated with SARS-CoV-2 disease. A previous study had estimated that in the United States, 5.6% of adults have BE, a disease where esophageal squamous mucosa gets damaged by GERD.

12 Sep 2021

Researchers find a way to turn SARS-CoV-2’s virulence mechanism against itself

A recent study, currently available on the bioRxiv* preprint server, reveals that a specific region of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be targeted by antisense oligonucleotides to potently inhibit viral replication, and consequently the development of coronavirus disease (COVID-19).

12 Sep 2021

Lessons from COVID-19 response during first three waves in New South Wales

Scientists from Australia have recently analyzed the public health measures adopted by the authorities during the three waves of coronavirus disease 2019 (COVID-19) pandemic in New South Wales, Australia.

12 Sep 2021

Scientists develop a novel and potent SARS-CoV-2 RBD-homodimer vaccine

A recent report published in the journal Cell Discovery has described the immunogenicity and protective efficacy of a novel coronavirus disease 2019 (COVID-19) subunit vaccine candidate. The vaccine induces robust immune responses in rodents and non-human primates and protects the animals against severe disease.

12 Sep 2021

Researchers identify the spleen as primary site for priming of 'killer' T cells during influenza infection

CD8+ T cells - known as "killer" T cells - are the assassins of the immune system. Once they are primed, they seek out and destroy other cells that are infected with virus or cells that are cancerous.

12 Sep 2021

The strengths and weaknesses of the spike protein in SARS-CoV-2 variants

The S protein has the ability to appropriate various conformations that are dependent on the formation of the receptor-binding domain (RBD) of its protomers.

12 Sep 2021

Does Delta increase the risk of hospitalization compared with Alpha?

A team of researchers conducted a cohort study to understand the risk of hospitalization in patients with either the Delta or Alpha variants of SARS-CoV-2.

12 Sep 2021

Microscopy paired with AI leads to a fast, accurate, and cost-effective COVID-19 test

Beckman researchers paired microscopy with artificial intelligence to develop a COVID-19 test that's fast, accurate, and cost-effective. All we need to do is say "ahh."

12 Sep 2021

Drugs that mimic effects of cigarette smoke could become a potential tool to fight COVID-19

Researchers have identified two drugs that mimic the effect of chemicals in cigarette smoke to bind to a receptor in mammalian cells that inhibits production of ACE2 proteins, a process that appears to reduce the ability of the SARS-CoV-2 virus to enter the cell.

12 Sep 2021

UGA research offers hope for a viable therapeutic to combat COVID-19

As COVID-19 cases continue to skyrocket across the U.S. and the world, few options are available for treating patients infected with the SARS-CoV-2.

11 Sep 2021

Brown researchers receive $4.9 million to study COVID-19 vaccine effectiveness in older adults

To address the pressing issue of diminishing immunity among older adults to COVID-19 as well to vaccines designed to protect against the virus, a $4.9 million award from the U.S. Centers for Disease Control and Prevention will fund a two-year project led by Brown University researchers and conducted by a team spanning multiple institutions.

10 Sep 2021

Convalescent plasma does not reduce risk of intubation or death for COVID-19 hospitalized patients

A major study has found that convalescent plasma does not reduce the risk of intubation or death for COVID-19 patients.

10 Sep 2021

Study identifies FDA-approved drugs that are effective in suppressing SARS-CoV-2 replication

Despite the development of SARS-CoV-2 vaccines, effective therapeutics are needed until worldwide immunity has been achieved.

10 Sep 2021

Genomic surveillance of SARS-CoV-2 reveals how the pandemic was caused in Africa

A genomic surveillance analysis of SARS-CoV-2 in Africa in the first year of the pandemic reveals that the first phase of the pandemic there was caused by importations from outside Africa, and involved limited virus spread, while the second, more deadly phase was fueled by ongoing transmission within the continent and led to emergence of many variants of concern.

10 Sep 2021

Virus News and Research

Latest Virus News and Research

Functional impairment of HIV-specific T cells precedes aborted virus control

As COVID restrictions were removed, Texas saw an increase in seasonal respiratory virus infections

An investigation of SARS-CoV-2 infections among Australian passengers on the Diamond Princess cruise ship

Acid pH enhances SARS-CoV-2 infection by up-regulating ACE2 receptor

Researchers find a way to turn SARS-CoV-2’s virulence mechanism against itself

Lessons from COVID-19 response during first three waves in New South Wales

Scientists develop a novel and potent SARS-CoV-2 RBD-homodimer vaccine

Researchers identify the spleen as primary site for priming of 'killer' T cells during influenza infection

The strengths and weaknesses of the spike protein in SARS-CoV-2 variants

Does Delta increase the risk of hospitalization compared with Alpha?

Microscopy paired with AI leads to a fast, accurate, and cost-effective COVID-19 test

Drugs that mimic effects of cigarette smoke could become a potential tool to fight COVID-19

UGA research offers hope for a viable therapeutic to combat COVID-19

Brown researchers receive $4.9 million to study COVID-19 vaccine effectiveness in older adults

Convalescent plasma does not reduce risk of intubation or death for COVID-19 hospitalized patients

Study identifies FDA-approved drugs that are effective in suppressing SARS-CoV-2 replication

Genomic surveillance of SARS-CoV-2 reveals how the pandemic was caused in Africa

Nanoparticles-assisted delivery of antiviral-siRNA for treatment of COVID-19

Breastfeeding women and their babies: the outcomes after mRNA COVID-19 vaccination

Virus-like nanoparticle vaccine effective against SARS-CoV-2 in animal model

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in